๐Ÿ“ข New Earnings In! ๐Ÿ”

Twist Bioscience Corporation

TWST

Healthcare
Medical - Diagnostics & Research
US

Company Overview

Detailed information about Twist Bioscience Corporation

Basic Information
Ticker: TWST
Country: US
Headquarter: South San Francisco, CA
Employees: 923
Financial Information
Market Cap: $2.3 Billion
Currency: USD
Sector: Healthcare
Industry: Medical - Diagnostics & Research

Stock Data provided by Financial Modeling Prep

Company Description

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.

Last Updated: Jul 2025

Here's what you can ask